BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL

Catalog number BNC742759-100

Price for BNC742759-100

Size / count 1x 100 µL

About this product

BarX1 is a member of the Bar subclass of homeobox transcription factors. Studies of the Mouse and chick homolog suggest the encoded protein may play a role in developing teeth and craniofacial mesenchyme of neural crest origin. The protein may also be associated with differentiation of stomach epithelia. Down-regulation of Barx1 promotes hepatocellular carcinoma cell (HCC) migration, invasion and metastasis, whereas up-regulation of Barx1 inhibits HCC migration, invasion and metastasis. The loss of Barx1 expression represents a prognostic biomarker in human HCC. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC742759-100
Size / count: 1x 100 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: BARX1; Homeobox protein BarH-like 1; BARX homeobox 1
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: BARX1
Gene ID: 56033
NCBI Gene ID: 164960
UniProt: Q9HU1
Swiss Prot: Q9HU1
Host: Mouse
Species Reactivity: Human
Reactivity: BARX1
Immunogen: Recombinant fragment of human BARX1 protein (around aa 155-254) (exact sequence is proprietary)
Target Antigen: BARX1
Clonality: Monoclonal
Clone: BARX1/2759
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Transcription factor
Positive Control: HepG2 cell lysate. Pancreas.
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% rBSA, 0.05% azide
Molecular Weight: 24 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), Bos taurus (bovine)
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF740

Frequently Asked Questions

What is the catalog number for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL?

The catalog number for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL is BNC742759-100.

What sizes are available for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL?

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL is available in the following size(s): 1x 100 µL.

Is BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL in stock?

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL?

BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL?

Estimated delivery time for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL?

The safety data sheet for BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL is available here: https://biotium.com/wp-content/uploads/2018/06/SDS-primary-antibodies.pdf.

What is BARX1 (Prognostic Biomarker in Hepatocellular Carcinoma) (BARX1/2759), CF740 conjugate, 0.1mg/mL used for?

How do I reconstitute this lyophilized product?

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

What is the recommended incubation time for this antibody?

A suggested incubation time is provided in the recommended protocol on the datasheet, but may need adjusting depending on your sample type and detection system.

What should I check when this product first arrives?

Inspect the package immediately for transportation damage, ice loss, leakage, or breakage. Report any issues right away with photos and your order reference; our specialists will determine whether the product is still usable or needs replacing.